Search research articles
Contact Us
Filters
Showing results (141-150 of 302) with videos related to
Page
of 31
Sort By:
Gynecologic Oncology
|
November 26, 2016
Less radical surgery for early-stage cervical cancer: Can conization specimens help identify patients at low risk for parametrial involvement?
Blair Smith, Georgia A McCann, Gary Phillips, et al.
The American Journal of Surgical Pathology
|
October 15, 2016
The Microcystic, Elongated, and Fragmented (MELF) Pattern of Invasion: A Single Institution Report of 464 Consecutive FIGO Grade 1 Endometrial Endometrioid Adenocarcinomas
Amy S Joehlin-Price, Kelsey E McHugh, Julie A Stephens, et al.
Gynecologic Oncology
|
February 6, 2017
Recurrent low grade serous ovarian cancer in a 20 year old woman: A case from the Ohio State University College of Medicine
David E Cohn, Floor J Backes, John J Wallbillich, et al.
Gynecologic Oncology
|
December 8, 2004
Morbid obesity and endometrial cancer: surgical, clinical, and pathologic outcomes in surgically managed patients
James C Pavelka, Inbar Ben-Shachar, Jeffrey M Fowler, et al.
Obstetrics and Gynecology
|
June 24, 2009
Comprehensive surgical staging for endometrial cancer in obese patients: comparing robotics and laparotomy
Leigh G Seamon, Shannon A Bryant, Patrick S Rheaume, et al.
Gynecologic Oncology
|
May 31, 2013
Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: an early glimpse into a challenging initiative
David E Cohn, Mario Leitao, Charles Levenback, et al.
Gynecologic Oncology
|
May 3, 2011
A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: a Gynecologic Oncology Group Study
Robert S Mannel, Mark F Brady, Elise C Kohn, et al.
Gynecologic Oncology
|
August 14, 2012
Recurrent ovarian cancer: is there a role for re-treatment with bevacizumab after an initial complete response to a bevacizumab-containing regimen?
Georgia A McCann, Blair Smith, Floor J Backes, et al.
Journal of Robotic Surgery
|
September 18, 2016
Robotic hysterectomy and lymphadenectomy for endometrial cancer: technical aspects and details of success-the Ohio State University method
Leigh G Seamon, David E Cohn, Sue Valmadre, et al.
Gynecologic Oncology
|
March 3, 2018
Estimating potential for savings for low risk endometrial cancer using the Endometrial Cancer Alternative Payment Model (ECAP): A companion paper to the Society of Gynecologic Oncology Report on the Endometrial Cancer Alternative Payment Model
Jason D Wright, Laura J Havrilesky, David E Cohn, et al.
Page
of 31
Search research articles
Search
Showing results (141-150 of 302) with videos related to
Sort By:
Page
of 31
Gynecologic Oncology
|
November 26, 2016
Less radical surgery for early-stage cervical cancer: Can conization specimens help identify patients at low risk for parametrial involvement?
Blair Smith, Georgia A McCann, Gary Phillips, et al.
The American Journal of Surgical Pathology
|
October 15, 2016
The Microcystic, Elongated, and Fragmented (MELF) Pattern of Invasion: A Single Institution Report of 464 Consecutive FIGO Grade 1 Endometrial Endometrioid Adenocarcinomas
Amy S Joehlin-Price, Kelsey E McHugh, Julie A Stephens, et al.
Gynecologic Oncology
|
February 6, 2017
Recurrent low grade serous ovarian cancer in a 20 year old woman: A case from the Ohio State University College of Medicine
David E Cohn, Floor J Backes, John J Wallbillich, et al.
Gynecologic Oncology
|
December 8, 2004
Morbid obesity and endometrial cancer: surgical, clinical, and pathologic outcomes in surgically managed patients
James C Pavelka, Inbar Ben-Shachar, Jeffrey M Fowler, et al.
Obstetrics and Gynecology
|
June 24, 2009
Comprehensive surgical staging for endometrial cancer in obese patients: comparing robotics and laparotomy
Leigh G Seamon, Shannon A Bryant, Patrick S Rheaume, et al.
Gynecologic Oncology
|
May 31, 2013
Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: an early glimpse into a challenging initiative
David E Cohn, Mario Leitao, Charles Levenback, et al.
Gynecologic Oncology
|
May 3, 2011
A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: a Gynecologic Oncology Group Study
Robert S Mannel, Mark F Brady, Elise C Kohn, et al.
Gynecologic Oncology
|
August 14, 2012
Recurrent ovarian cancer: is there a role for re-treatment with bevacizumab after an initial complete response to a bevacizumab-containing regimen?
Georgia A McCann, Blair Smith, Floor J Backes, et al.
Journal of Robotic Surgery
|
September 18, 2016
Robotic hysterectomy and lymphadenectomy for endometrial cancer: technical aspects and details of success-the Ohio State University method
Leigh G Seamon, David E Cohn, Sue Valmadre, et al.
Gynecologic Oncology
|
March 3, 2018
Estimating potential for savings for low risk endometrial cancer using the Endometrial Cancer Alternative Payment Model (ECAP): A companion paper to the Society of Gynecologic Oncology Report on the Endometrial Cancer Alternative Payment Model
Jason D Wright, Laura J Havrilesky, David E Cohn, et al.
Page
of 31